News

Posted in News

EpiAxis Therapeutics, a University of Canberra spin out company, has expanded its clinical trial program to include two additional recruitment centres for its Phase 1b metastatic breast cancer program.  Those centres are open for patient recruitment at the Southern Medical Day Care Centre in Wollongong and at the Liverpool Cancer Therapy Centre, which is based…

Read more

Posted in News

EpiAxis Phase 1 FPI News Release

Read more

1 2